Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer - abstract
Favorite
Share
More Options
20

Open in WPS to view all 20 pages
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
